Goodbody Health Ltd (AQSE:GDBY, OTCQB:GDBYF) said it has signed a contract with blood testing company Thriva as it continues to make progress on extending its phlebotomy services.
A phlebotomy is when blood is taken from your body via a needle.
The partnership will initially start as a trial with 82 of the Goodbody clinics, although others are expected to be added, according to a statement from the health wellness provider.
"We are very excited about this trial with Thriva as it continues to utilise the network of phlebotomists and latest technology we have built, and will continue to build, to support Goodbody and its partners to provide customers with accurate results and increased positive outcomes,” said chief executive George Thomas.
Thriva has over 500,000 customers and is one of the UK’s largest health technology companies, operating in both the consumer and corporate space.